SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-23-003406
Filing Date
2023-06-02
Accepted
2023-06-02 17:33:07
Documents
1
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4250
  Complete submission text file 0000902664-23-003406.txt   6211
Mailing Address C/O CRINETICS PHARMACEUTICALS, INC. 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address
Nichols Weston (Reporting) CIK: 0001746376 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40603 | Film No.: 23990357

Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Issuer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607
Business Address 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 703-963-7214
Lynx1 Capital Management LP (Reporting) CIK: 0001910456 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40603 | Film No.: 23990358